 £116.4m
(2016: £103.4m)
£14.4m
(2016: £14.0m)
£148.8m
(2016: £129.3m)
OUR BUSINESS AT A GLANCE
We are made up of two distinct and 
separate businesses: Healthcare and 
Industrial, each with its own focus and 
strategy. With a global reach in each 
of the markets in which we participate, 
we are focused on sustainable growth 
and innovation, improving the solutions for 
our customers by applying our knowledge 
and expertise in advanced material 
technology and process solutions.
A trusted strategic 
outsource partner to 
the global healthcare 
industry, delivering  
turn-key solutions 
and support for our 
customers through 
all stages of the  
product life cycle.
The Industrial business 
operates across a 
wide range of markets 
and geographies. 
It manufactures and  
delivers an extensive 
portfolio of adhesive 
bonding solutions and 
applications to a global 
customer base.
REVENUE BY GEOGRAPHY
 Europe  
 Asia 
 North America
HEALTHCARE
INDUSTRIAL
 Turn to page 20
 Turn to page 24
REVENUE
£108.7m
(2016: £93.3m)
REVENUE
£170.9m
(2016: £153.4m)
2 SECTION TITLE: PAGE REF 2 STRATEGIC REPORT  
TRADING PROFIT*
£16.6m
(2016: £14.0m)
MARGIN
 15.3%
(2016: 15.0%)
TRADING PROFIT*
£17.8m
(2016: £10.7m)
MARGIN
 10.4%
(2016: 7.0%)
GLOBAL LOCATIONS
HIGHLIGHTS
• EuroMed now fully integrated and 
contributing well to H2 performance
• Three-year agreements signed with 
major customers in Consumer Wellness 
and Medical Devices
• Increased sales of turn-key products 
contributing to margin improvement
• New products launched for acne 
treatment, insulin delivery system 
and wound care
• Positive outlook for FY18 with good  
sales pipeline
HIGHLIGHTS
• Double-digit margins achieved – focus 
now to increase margins further to 
industry average mid-teens
• Rorschach closure executed well 
and £1m of benefits delivered in H2 
as promised
• Good progress on operational efficiency 
and supply chain costs
• Growth in sales in key segments – good 
results for innovative products specified 
into Auto and Cable customers, and 
improvement in the construction section 
where we exceeded GDP growth
MARKET SNAPSHOT
The market sectors we focus on today 
are Advanced Wound Care, Consumer 
Wellness and Medical Devices, including 
the rapidly growing Wearable Medical 
Device Fixation market. With our global 
footprint we can service and support all 
customer needs wherever they may be.
MARKET SNAPSHOT
The market sectors on which we 
focus include Automotive, Cable, 
Construction, Consumer and Specialty 
Products. These are split into Engineered 
Products – designed for specific customer 
applications – and Consumer, serviced 
through distributors.
Scapa Americas 
Brazil – São Paulo
Canada – Renfrew
USA – Inglewood, Knoxville, Liverpool, 
Orangeburg, Windsor
Scapa Europe 
France – Valence
Italy – Ghislarengo
UK – Dunstable, Manchester, Luton, 
Ramsbury
Scapa Asia 
China – Hong Kong, Shanghai, Shenzhen
India – Chennai
Korea – Chungyang, Anyang
Malaysia – Shah Alam
 Turn to page 20
 Turn to page 24
*  Trading profit for the Group is £29.2m which includes £5.2m of Corporate costs
STRATEGIC REPORT
2 SECTION TITLE: PAGE REF SCAPA GROUP PLC ANNUAL REPORT AND ACCOUNTS 2017 3 2 STRATEGIC REPORT
